Genetic Technologies Management
Management criteria checks 0/4
Genetic Technologies' CEO is Michael Walker, appointed in May 2025, has a tenure of less than a year. directly owns 87.13% of the company’s shares, worth $29.46M. The average tenure of the management team and the board of directors is 0.8 years and 0.4 years respectively.
Key information
Michael Walker
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 87.1% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Michael Walker
Mr. Michael Walker is Executive Chairman & MD of Genetic Technologies Limited from May 14, 2025.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer of EasyDNA | 4.2yrs | AU$296.12k | no data | |
| Executive Chairman & MD | less than a year | no data | 87.13% $ 29.5m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Consultant | 6.3yrs | AU$180.45k | no data | |
| Joint Company Secretary | 1.3yrs | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data | |
| Director of Clinical & Scientific Affairs | no data | no data | no data |
Experienced Management: GNTL.F's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & MD | less than a year | no data | 87.13% $ 29.5m | |
| Member of Scientific & Medical Advisory Board | 3.9yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | 3.9yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | 3.9yrs | no data | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | less than a year | no data | no data |
Experienced Board: GNTL.F's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/22 08:45 |
| End of Day Share Price | 2025/07/25 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genetic Technologies Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kevin DeGeeter | Ladenburg Thalmann & Company |
| Chris Kallos | MST Financial Services Pty Limited |